81 related articles for article (PubMed ID: 2803140)
1. Haloperidol decanoate.
Nasser J; Thomas B
Aust N Z J Psychiatry; 1989 Sep; 23(3):311-2. PubMed ID: 2803140
[No Abstract] [Full Text] [Related]
2. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy.
arap Mengech HN; Wazome EG
East Afr Med J; 1984 Jun; 61(6):435-8. PubMed ID: 6152736
[No Abstract] [Full Text] [Related]
3. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
[TBL] [Abstract][Full Text] [Related]
4. Expressed emotion, maintenance pharmacotherapy, and schizophrenic relapse among Mexican-Americans.
Jenkins JH; Karno M; de la Selva A; Santana F; Telles C; Lopez S; Mintz J
Psychopharmacol Bull; 1986; 22(3):621-7. PubMed ID: 3797568
[No Abstract] [Full Text] [Related]
5. Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics.
Chang WH; Lin SK; Juang DJ; Chen LC; Yang CH; Hu WH; Chien CP; Lam YF; Jann MW
Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jan; 17(1):105-12. PubMed ID: 8416597
[TBL] [Abstract][Full Text] [Related]
6. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
7. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
Roncoroni D
Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
[TBL] [Abstract][Full Text] [Related]
8. A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder.
Pomykacz B; Mao M; Weiss RD; Teter CJ
Harv Rev Psychiatry; 2007; 15(5):259-63. PubMed ID: 17924260
[No Abstract] [Full Text] [Related]
9. Plasma haloperidol and reduced haloperidol concentrations in a geriatric population.
Chang WH; Jann MW; Chiang TS; Lin HN; Hu WH; Chien CP
Neuropsychobiology; 1996; 33(1):12-6. PubMed ID: 8821369
[TBL] [Abstract][Full Text] [Related]
10. Depot neuroleptics and manic depressive psychosis.
Lowe MR; Batchelor DH
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():53-62. PubMed ID: 3559161
[TBL] [Abstract][Full Text] [Related]
11. Effects of haloperidol decanoate on plasma homovanillic acid in chronic schizophrenic patients.
Chang WH; Lin SK; Juang DJ; Chen LC; Yang CH; Lane HY; Jann MW
Biol Psychiatry; 1993 Apr; 33(7):557-9. PubMed ID: 8513043
[No Abstract] [Full Text] [Related]
12. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
[TBL] [Abstract][Full Text] [Related]
13. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Wistedt B
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
[TBL] [Abstract][Full Text] [Related]
14. Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
Meco G; Casacchia M; Attenni M; Iafrate A; Castellana F; Ecari U
Acta Psychiatr Belg; 1983; 83(1):57-68. PubMed ID: 6613612
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial strategies for maximizing the effects of psychotropic medications for schizophrenia and mood disorder.
Goldstein MJ
Psychopharmacol Bull; 1992; 28(3):237-40. PubMed ID: 1480725
[TBL] [Abstract][Full Text] [Related]
16. The use of depot neuroleptic haloperidol decanoate.
Fernando J; Krishna Raju R; Jones GG; Stanley RO
Acta Psychiatr Scand; 1984 Feb; 69(2):175-6. PubMed ID: 6702478
[TBL] [Abstract][Full Text] [Related]
17. Acutely psychotic patients receiving high-dose haloperidol therapy.
Remington G; Pollock B; Voineskos G; Reed K; Coulter K
J Clin Psychopharmacol; 1993 Feb; 13(1):41-5. PubMed ID: 8486816
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of clinical usefulness of decaldol (haloperidol decanoate) produced by WZF Polfa in Warsaw in long-term treatment of schizophrenia].
Morasiewicz J; Baranowski P; Borys J; Jańska-Skomorowska M; Kiejna A
Psychiatr Pol; 1995; 29(3):405-20. PubMed ID: 7652093
[TBL] [Abstract][Full Text] [Related]
19. [Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses].
Cesková E; Svestka J; Rysánek R
Cesk Psychiatr; 1993 Jan; 89(1):11-4. PubMed ID: 8099534
[TBL] [Abstract][Full Text] [Related]
20. [Pharmaco-clinical correlations during fluoxetine administration in patients with depressive schizophrenia treated with haloperidol decanoate].
Viala A; Aymard N; Leyris A; Caroli F
Therapie; 1996; 51(1):19-25. PubMed ID: 8762216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
